Latest news

• More fatigue in progressive MS
• How oligodendrocytes repair myelin

Researchers identified a number of factors which influenced health professionals prescribing of disease modifying drugs in the UK.

• Stem cells effective in aggressively relapsing MS
• Benefits of early DMD treatment
• Guidelines for MS treatment during pregnancy published
• Mindfulness helps mood and fatigue

An international study for people with highly active relapsing multiple sclerosis has reported that those having stem cell treatment had slower disability progression.

• Cooling helps with exercise
• Rituximab and SPMS
• Ocrevus and arm function in PPMS
• Plasma cells from gut can turn off brain inflammation

New guidelines for pregnancy care in multiple sclerosis, drawn up by a panel of UK experts including the MS Trust, have been published.

Are you a sports massage therapist? The MS Trust needs you!

• Relapses more likely in people with food allergies
• Reducing Ocrevus injection site reactions
• Fampridine and walking speed

This small clinical trial tested the potential of Epstein-Barr virus-specific T cell therapy in secondary and primary progressive MS.

Living with MS in the family does not only affect the person with MS, but their loved ones as well. In this guest blog, Jen who is a full time carer for her husband Dave, writes about their life living with advanced MS.

• SMC approves Ocrevus
• Australian stem cell study
• Switching interferons increases relapse risk

The Scottish Medicines Consortium (SMC) has approved Ocrevus (ocrelizumab) as an NHS treatment for relapsing remitting multiple sclerosis in Scotland.